Product Information
Registration Status: ActiveSIN15308P
PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G is approved to be sold in Singapore with effective from 2017-07-31. It is marketed by FRESENIUS KABI (SINGAPORE) PTE LTD, with the registration number of SIN15308P.
This product contains Piperacillin 4.0 g, and Tazobactam 0.5g in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for INTRAVENOUS use.
This product is manufactured by Labesfal - Laboratorios Almiro S.A. (Fresenius Kabi Group) in ITALY, andFresenius Kabi iPSUM Srl (Pozzilli plant) (Intermediate) in PORTUGAL.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic proposed for pseudomonas infections. It is also used in combination with other antibiotics. [PubChem]
Indication
For the treatment of polymicrobial infections.
Mechanism of Action
By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Piperacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Piperacillin interferes with an autolysin inhibitor.
Pharmacokinetics
- Absorption
- Not absorbed following oral administration.
- Distribution
- * 101 mL/kg [intravenous administration of 50 mg/kg (5-minute infusion) in neonates]
- Metabolism
- Largely not metabolized.
- Elimination
Clearance
* 32 - 41 mL/min/1.73 m2 * 124 - 160 mL/min/1.73 m2 [older pediatric patients]
Active Ingredient/Synonyms
(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Piperacilina | Piperacillin | Piperacillin Anhydrous | Piperacillina | Pipéracilline | Piperacillinum | Piperacillin |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Description
Tazobactam is a antibacterial penicillin derivative which inhibits the action of bacterial beta-lactamases.
Indication
Used in combination with piperacillin to broaden the spectrum of piperacillin antibacterial action.
Mechanism of Action
Tazobactam broadens the spectrum of piperacillin by making it effective against organisms that express beta-lactamase and would normally degrade piperacillin.
Active Ingredient/Synonyms
CL-298741 | Tazobactam | YTR-830H | Tazobactam |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.